News

Bayer Consumer Care (BCC) has launched Citracal Calcium Plus Heart Health, a calcium supplement to help support bone and heart health. Bayer claimed that the new supplement addresses

Theravance and Astellas Pharma have commercially launched Vibativ (telavancin) in the US. FDA approved Vibativ for the treatment of adult patients with complicated skin and skin structure infections

NeuroVive Pharmaceutical has completed the clinical phase of its study investigating tolerability and pharmacokinetics of the cremophor-free cyclosporine formula NeuroSTAT. The study is entitled: “A study to compare

BioCryst Pharmaceuticals has received an initial order for 10,000 courses of intravenous (i.v.) peramivir (600 mg once-daily for five days) with a value of $22.5m under a newly

Using Catalent’s drug delivery technologies, the two companies will collaborate exclusively to develop certain oral formulations of small-glycol drugs. Oral formulations of synthetic oligosaccharides will allow full exploitation

Helix BioPharma has completed patient enrollment in its phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW), with the required 120th patient randomized

Under the agreement, Aureus will provide AurSCOPE knowledge databases and continue to update existing databases for Sanofi-Aventis’ R&D division. These databases are expected to give Sanofi-Aventis researchers access

Superior Global Software, has completed the acquisition of assets and business of HTI Technologies, Georgia. Under the terms of the agreement, Superior Global purchased substantially all of the

In newborn screening programs, infants are tested for a range of genetic, metabolic or hematologic disorders. When identified within the first few days of life, these disorders are